Related Experiment Video
Updated: Sep 28, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience
1Department of Internal Medicine and Public Health--Hygiene Section, University of Bari, Italy. r.monno@igieneseconda.uniba.it
Objectives:
To determine the prevalence of Chlamydia pneumoniae in community-acquired pneumonia during a period of seven years.
Methods:
Serum samples from 311 patients with pneumonia were evaluated using microimmunofluorescence assay to detect C. pneumoniae -specific IgG and IgM antibodies.
Results:
Thirty nine patients (12.5%) complied with the diagnostic criteria of acute C. pneumoniae infection (a four-fold rise in the titer of IgG antibody, or a single IgG titer > or = 1:512, or a single IgM titer > or = 1:16). All patients were diagnosed as having pneumonia. Co-infection with other respiratory tract pathogens was found in four patients.
Conclusions:
C. pneumoniae is an important cause of pneumonia also in our area. Pneumonia due to this bacterium occurs in the cold months and in early spring; in addition we have observed periods of increased incidence of one years duration and periods of low incidence lasting one-two years. Therapy with macrolides and levofloxacin was effective in all patients with C. pneumoniae infection.
Insights
Chlamydia pneumoniae causes 12.5% of community-acquired pneumonia cases. This bacterial pneumonia is more common in colder months and responds well to macrolide and levofloxacin therapies.
Area of Science:
- Infectious Diseases
- Respiratory Medicine
- Microbiology
Background:
- Community-acquired pneumonia (CAP) poses a significant public health challenge.
- Identifying specific causative pathogens like Chlamydia pneumoniae is crucial for effective treatment and epidemiological understanding.
Purpose of the Study:
- To ascertain the prevalence of Chlamydia pneumoniae as a cause of CAP over a seven-year period.
- To characterize the epidemiological patterns and treatment outcomes for C. pneumoniae pneumonia.
Main Methods:
- A retrospective analysis of 311 patients diagnosed with pneumonia.
- Serological testing using microimmunofluorescence assay to detect specific IgG and IgM antibodies against C. pneumoniae.
Main Results:
- Chlamydia pneumoniae infection was diagnosed in 12.5% of CAP patients based on established serological criteria.
- The incidence of C. pneumoniae pneumonia exhibited seasonal variations, peaking in colder months and early spring, with multi-year cyclical patterns observed.
- Co-infection with other respiratory pathogens occurred in a small subset of patients (4).
Conclusions:
- Chlamydia pneumoniae is a significant etiological agent of pneumonia in the studied region.
- The findings highlight the importance of considering C. pneumoniae in CAP diagnoses, particularly during specific seasons.
- Effective treatment regimens included macrolides and levofloxacin, demonstrating good therapeutic response.
Related Concept Videos
01:14Atypical Pneumonia
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.